Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.

Ruys AT, van Beem BE, Engelbrecht MR, Bipat S, Stoker J, Van Gulik TM.

Br J Radiol. 2012 Sep;85(1017):1255-62. doi: 10.1259/bjr/88405305. Review.

2.

Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.

Li J, Kuehl H, Grabellus F, Müller SP, Radunz S, Antoch G, Nadalin S, Broelsch CE, Gerken G, Paul A, Kaiser GM.

J Surg Oncol. 2008 Nov 1;98(6):438-43. doi: 10.1002/jso.21136.

PMID:
18767120
3.

Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis.

Annunziata S, Caldarella C, Pizzuto DA, Galiandro F, Sadeghi R, Giovanella L, Treglia G.

Biomed Res Int. 2014;2014:247693. doi: 10.1155/2014/247693. Epub 2014 May 13.

4.

[Management of hilar cholangiocarcinoma].

Muscari F.

J Chir (Paris). 2007 Sep-Oct;144(5):385-92. Review. French.

PMID:
18065892
5.

Imaging of perihilar cholangiocarcinoma.

Engelbrecht MR, Katz SS, van Gulik TM, Laméris JS, van Delden OM.

AJR Am J Roentgenol. 2015 Apr;204(4):782-91. doi: 10.2214/AJR.14.12830. Review.

PMID:
25794067
6.

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH.

Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9.

7.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
8.

[Hilar cholangiocarcinoma].

Miyazaki M, Ito H, Kimura F, Shimizu H, Togawa A, Ohtsuka M, Yoshidome H, Kato A, Yoshitomi H, Sawada S, Ambiru S.

Nihon Geka Gakkai Zasshi. 2005 Apr;106(4):291-6. Japanese.

PMID:
15859140
9.

Diagnostic role of staging laparoscopy in a subset of biliary cancers: a meta-analysis.

Tian Y, Liu L, Yeolkar NV, Shen F, Li J, He Z.

ANZ J Surg. 2017 Jan;87(1-2):22-27. doi: 10.1111/ans.13762. Epub 2016 Sep 20. Review.

PMID:
27647697
10.

Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D'Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR.

Ann Surg. 2006 Aug;244(2):260-4.

11.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

12.

Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning.

Masselli G, Gualdi G.

Abdom Imaging. 2008 Jul-Aug;33(4):444-51. Review.

PMID:
17638040
13.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
14.

Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions.

Hänninen EL, Pech M, Jonas S, Ricke J, Thelen A, Langrehr J, Hintze R, Röttgen R, Denecke T, Winter L, Neuhaus P, Felix R.

Acta Radiol. 2005 Aug;46(5):462-70.

PMID:
16224919
15.

Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review.

Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J.

Gynecol Oncol. 2003 Oct;91(1):59-66. Review.

PMID:
14529663
16.

Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography.

Ringe KI, Wacker F.

Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):253-65. doi: 10.1016/j.bpg.2015.02.004. Epub 2015 Feb 17. Review.

PMID:
25966426
17.

Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?

Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S.

Surgery. 2007 May;141(5):581-8. Epub 2007 Mar 23.

PMID:
17462457
18.

Intrahepatic cholangiocarcinoma.

Poultsides GA, Zhu AX, Choti MA, Pawlik TM.

Surg Clin North Am. 2010 Aug;90(4):817-37. doi: 10.1016/j.suc.2010.04.011. Review.

PMID:
20637950
19.

Hilar cholangiocarcinoma.

Zaydfudim VM, Rosen CB, Nagorney DM.

Surg Oncol Clin N Am. 2014 Apr;23(2):247-63. doi: 10.1016/j.soc.2013.10.005. Review.

PMID:
24560109
20.

Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography.

Cho ES, Park MS, Yu JS, Kim MJ, Kim KW.

J Comput Assist Tomogr. 2007 Jan-Feb;31(1):72-8.

PMID:
17259836

Supplemental Content

Support Center